Otezla (apremilast) is a prescription medication used to treat certain inflammatory conditions, such as psoriasis and psoriatic arthritis. It works by blocking an enzyme called phosphodiesterase 4 (PDE4), which plays a role in inflammation.
By blocking this protein, Otezla can help reduce inflammation and relieve symptoms associated with these conditions, including skin plaques, joint pain, and swelling.
However, as a healthcare provider, obtaining access to Otezla enrollment forms can be time-consuming and confusing. In this article, we will provide you with access to Otezla enrollment forms and introduce you to the Otezla SupportPlus™ Program – which provides a variety of HCP and patient resources to streamline the process of prescribing Otezla to treat patients.